A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

Clinical trial NCT05723835 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05723835
Sponsor: Novo Nordisk A/S
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

SGA Turner Syndrome Noonan Syndrome ISS

Start date: 2023-02-01
Primary completion: 2024-06-07
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.